It has been shown that Shigella species produce a low-level chromosomally mediated β-lactamase which does not appreciably affect the level of resistance to β-lactams (2, 10). High rates of resistance to ampicillin among Shigella isolates are due to the production of β-lactamases similar to TEM-1 or OXA-1. The OXA-type β-lactamase is more prevalent than TEM-1 in ampicillin-resistant Shigella flexneri (2, 6, 7, 8). In Shigella sonnei the most commonly produced β-lactamase is the TEM-1 enzyme (2, 6, 7).
We describe here an S. sonnei isolate which was identified by the API ID 32E system (Bio-Merieux) and by antiserum agglutination and which was obtained in 1998 from stool samples of an 8-year-old child hospitalized at Orléans Hospital (Orléans France) for diarrheal disease that appeared after a 2-month stay in Turkey. The strain was resistant to amoxicillin and ticarcillin, either as single drugs or in combination with clavulanate and piperacillin. It was also resistant to trimethoprim-sulfamethoxazole and tetracyclines and susceptible to all cephalosporins, to nalidixic acid, and to fluoroquinolones.
The purpose of the present study was to find the molecular basis of the resistance to amoxicillin-clavulanate in the S. sonnei isolate (UCK strain). A TEM-1-hyperproducing S. sonnei strain (CFS01) and an OXA-1-producing S. flexneri strain (CFS02) were studied as comparators for MIC determinations.
The MICs of amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate (clavulanic acid at a fixed concentration of 2 μg/ml), and cephalothin were determined by dilution in Mueller-Hinton agar (Sanofi Diagnostics Pasteur, Marnes-la-Coquette, France) with an inoculum of 104 CFU per spot.
The resistance pattern of S. sonnei UCK was characterized by high MICs of amoxicillin and ticarcillin alone (>2,048 μg/ml) and combined with clavulanate (2,048 μg/ml), while MICs for the OXA-1-producing S. flexneri CFS02 were much lower (amoxicillin, 256 μg/ml; amoxicillin-clavulanate, 64 μg/ml; ticarcillin, 256 μg/ml; ticarcillin-clavulanate, 32 μg/ml). Against S. sonnei CFS01 (TEM-1 hyperproducing), clavulanate partially restored the activities of amoxicillin and ticarcillin (MICs, 64 μg/ml for both combinations).
No transconjugant was obtained by mating of S. sonnei UCK with Escherichia coli HB101 as recipient strain with ticarcillin (32 μg/ml) as selective agent. Plasmid DNA content was determined by comparison with plasmids Rsa (39 kb), TP114 (61 kb), pCFF04 (85 kb), and pCFF14 (180 kb). Strain UCK contained one large plasmid of ca. 90 kb which hybridized with the TEM probe (data not shown). Isoelectric focusing performed with polyacrylamide gels containing ampholines with a pH range of 3.5 to 10.0 showed that the β-lactamase produced by S. sonnei UCK focused at a pI of 5.4.
The nucleotide sequence analysis obtained by direct sequencing of the PCR product revealed that the sequence of the bla gene differed from that of blaTEM-1b at two positions: a G-162→T transversion (at position 1 of the −10 consensus sequence) in the promoter region and the change A-407→C, leading to the amino acid substitution Met-69→Leu in the coding region. The latter change has already been observed in the inhibitor-resistant TEM β-lactamase IRT-5/TEM-33 (4).
Table 1 shows the sequences of the structural genes and of the promoter regions specifying this IRT enzyme. Three different blaTEM-33 genes which had the mutation A-407→C in common were reported by Goussard and Courvalin (3): blaTEM-33a, derived from blaTEM-1b with the change T-226→C, which is under the control of the weak P3 promoter (9); blaTEM-33b, derived from blaTEM-1b, which is under the control of the strong promoters Pa an Pb; and blaTEM-33c, derived from blaTEM-2 with the change A-317→C (Lys-39→Gln), with the promoter region corresponding to the strong P4 promoter with the T-32→C amd G-162→T mutations. The structural gene of IRT-5/TEM-33 produced by S. sonnei UCK is identical to blaTEM-33b. The promoter region had the change G-162→T (P4), which has been shown to be responsible for the hyperproduction of TEM-1 and which is commonly found upstream from the genes for inhibitor-resistant β-lactamases (3). This fourth gene coding for TEM-33 was designated blaTEM-33b-like.
TABLE 1.
Substitutions in blaTEM genes and derived genes encoding the inhibitor-resistant β-lactamase TEM-33/IRT-5
Nucleotidea (amino acidb) position | Nucleotide (amino acid)
|
||||||
---|---|---|---|---|---|---|---|
blaTEM-1a | blaTEM-1b | blaTEM-2 | blaTEM-33ad | blaTEM-33be | blaTEM-33ce | blaTEM-33b-likef | |
Promoter regiong | |||||||
32 | C | C | T | C | T | C | C |
162 | G | G | G | G | G | T | T |
175 | A | G | A | G | G | A | G |
Coding region | |||||||
226c | C (Phe) | T | C | C | T | C | T |
317 (39) | C (Gln) | C | A (Lys) | C | C | C | C |
346c | A (Gln) | A | G | A | A | G | A |
407 (69) | A (Met) | A | A | C (Leu) | C (Leu) | C (Leu) | C (Leu) |
436c | C (Gly) | T | T | T | T | T | T |
604c | G (Ala) | T | G | T | T | G | T |
682c | T (Thr) | T | C | T | T | C | T |
925c | G (Gly) | G | A | G | G | A | G |
Moderate resistance to amoxicillin-clavulanate (MIC90 = 16 μg/ml) has been frequently reported in S. flexneri isolates, which often produce a relatively inhibitor-resistant OXA-type enzyme (2, 8).
The high-level resistance to amoxicillin-clavulanate (2,048 μg/ml) associated with susceptibility to cephalothin (8 μg/ml) observed in S. sonnei (UCK strain) suggested the presence of a hitherto unreported TEM-33 variant in the species. The sequence diversity observed for the IRT-3/TEM-33 genes lends weight to the idea that there is a great variety of TEM genes in nature, as previously suggested by Goussard and Courvalin (3) and as recently reported by Leflon-Guibout et al. (5). In this study, the patient had received no antibiotics before the resistant strain was isolated.
Acknowledgments
We thank Rolande Perroux, Marlène Jan, and Dominique Rubio for technical assistance.
This work was supported in part by a grant from Ministère de l'Education Nationale, de la Recherche et de la Technologie.
REFERENCES
- 1.Ambler R P, Coulson A F W, Frère J M, Ghuysen J M, Joris B, Forsman M, Lévesque R C, Tiraby G, Waley S G. A standard numbering scheme for the class A β-lactamases. Biochem J. 1991;276:269–272. doi: 10.1042/bj2760269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Cavallo J D, Bercion R, Baudet J M, Samson T, France M, Meyran M. Antibiotic sensitivity of 140 strains of Shigella isolated in Djibouti. Bull Soc Pathol Exot. 1993;86:35–40. [PubMed] [Google Scholar]
- 3.Goussard S, Courvalin P. Updated sequence information for TEM β-lactamase genes. Antimicrob Agents Chemother. 1999;43:367–370. doi: 10.1128/aac.43.2.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Henquell C, Chanal C, Sirot D, Labia R, Sirot J. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM β-lactamases from clinical isolates of Escherichia coli. Antimicrob Agents Chemother. 1995;39:427–430. doi: 10.1128/aac.39.2.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Leflon-Guibout V, Speldooren V, Heym B, Nicolas-Chanoine M-H. Epidemiological survey of amoxicillin-clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of blaTEM genes. Antimicrob Agents Chemother. 2000;44:2709–2714. doi: 10.1128/aac.44.10.2709-2714.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Navia M M, Capitano L, Ruiz J, Vargas M, Urassa H, Schellemberg D, Gascon J, Villa J. Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania. J Clin Microbiol. 1999;37:3113–3117. doi: 10.1128/jcm.37.10.3113-3117.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Schumacher H, Nir M, Mansa B, Grassy A. β-Lactamases in Shigella. APMIS. 1992;100:954–956. [PubMed] [Google Scholar]
- 8.Siu L K, Lo J Y C, Yuen K Y, Chau P Y, Ng M H, Ho P L. β-Lactamases in Shigella flexneri isolates from Hong Kong and Shanghai and a novel OXA-1-like β-lactamase, OXA-30. Antimicrob Agents Chemother. 2000;44:2034–2038. doi: 10.1128/aac.44.8.2034-2038.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Speldooren V, Heym B, Labia R, Nicolas-Chanoine H-H. Discriminatory detection of inhibitor-resistant β-lactamases in Escherichia coli by single-strand conformation polymorphism-PCR. Antimicrob Agents Chemother. 1998;42:879–884. doi: 10.1128/aac.42.4.879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sutcliffe G. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc Natl Acad Sci USA. 1978;75:3727–3741. doi: 10.1073/pnas.75.8.3737. [DOI] [PMC free article] [PubMed] [Google Scholar]